---
title: "ZJJH: Net Profit of 3.783 Billion Yuan in 2025, Up 94.29% Year-on-Year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283640775.md"
description: "ZJJH expects revenue of 26.991 billion yuan in 2025, an increase of 10.33% year-on-year; net profit is expected to be 3.783 billion yuan, a rise of 94.29% year-on-year. The company plans to distribute cash dividends of 3.8 yuan per 10 shares (including tax) to all shareholders based on the total share count of 2.7 billion at the end of 2025. No stock dividends will be issued, and no capital reserve will be converted into share capital"
datetime: "2026-04-22T10:07:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283640775.md)
  - [en](https://longbridge.com/en/news/283640775.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283640775.md)
---

# ZJJH: Net Profit of 3.783 Billion Yuan in 2025, Up 94.29% Year-on-Year

ZJJH announced that revenue reached 26.991 billion yuan in 2025, up 10.33% year-on-year; net profit amounted to 3.783 billion yuan, a 94.29% increase year-on-year. The company intends to use the total share count of 2.7 billion at the end of 2025 as the base for distributing cash dividends of 3.8 yuan per 10 shares (including tax) to all shareholders. This year, no stock dividend distribution method will be adopted, nor will capital reserves be converted into share capital.

### Related Stocks

- [600160.CN](https://longbridge.com/en/quote/600160.CN.md)

## Related News & Research

- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Ohmium partners with RenewCO2 to advance CO2-to-chemicals technology](https://longbridge.com/en/news/287035805.md)
- [First healthy volunteers receive TRIV-573 doses in Triveni Bio’s Phase I trial](https://longbridge.com/en/news/286888745.md)
- [18:55 ETSino Biological lanza el kit de síntesis de proteínas sin células XPressMAX™](https://longbridge.com/en/news/286974640.md)
- [Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities | DTCFF Stock News](https://longbridge.com/en/news/286870222.md)